cefoperazone has been researched along with Pneumonia, Bacterial in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W; Lu, H; Wang, H; Wu, G; Yang, C; Yuan, C | 1 |
| Chen, L; Deng, Y; Lv, Q; Ruan, J; Zhu, X | 1 |
| Du, L; Long, Y; Shi, H; Shi, L; Sun, L; Wang, H; Xu, H; Zhen, Y; Zhu, J; Zou, B | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Huang, CT; Ko, WC; Lee, WS; Lin, HH; Lin, JC; Liu, JW; Liu, YC; Lu, MC; Tang, HJ; Wang, FD | 1 |
| Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y | 1 |
| Babarina, MB; Sanadze, AG; Sokolova, VI; Sychev, DA; Zaĭkov, DA | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Chen, P; Cheng, WC; Xiang, XD; Zan, JN | 1 |
| Mitrokhin, SD | 1 |
| Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
| Mukonin, AA; Ovsiankin, AV | 1 |
| Huang, JJ; Yu, JL; Zeng, Q | 1 |
| Liu, H; Liu, J; Xiong, S; Xiong, W; Xu, S; Xu, Y; Zhao, J | 1 |
| Ikeda, N; Matsuyama, N; Watanabe, K | 1 |
| Kumar, AV; Rao, NR | 1 |
2 review(s) available for cefoperazone and Pneumonia, Bacterial
| Article | Year |
|---|---|
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
[Pseudomonas aeruginosa pneumonia].
Topics: Cefoperazone; Cephalosporins; Diagnosis, Differential; Humans; Immunocompromised Host; Penicillins; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections | 1999 |
6 trial(s) available for cefoperazone and Pneumonia, Bacterial
| Article | Year |
|---|---|
Effectiveness of Cefoperazone-sulbactam alone and Combined with Tigecycline in the Treatment of Multi-drug Resistant Acinetobacter Baumannii Pulmonary Infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; China; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam; Tigecycline; Treatment Outcome | 2020 |
Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cefoperazone; Drug Therapy, Combination; Female; Haemophilus Infections; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Sulbactam; Treatment Outcome | 2019 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
[Clinical and bacteriological substantiation of the use of cefoperazone/sulbactam in complex therapy of patients with pyo-destructive forms of lower respiratory tract infection (LRTI)].
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sulbactam | 2004 |
[Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Topics: Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Pneumonia, Bacterial; Sulbactam | 2005 |
Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia.
Topics: Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefoperazone; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Quinolines; Treatment Outcome | 2006 |
7 other study(ies) available for cefoperazone and Pneumonia, Bacterial
| Article | Year |
|---|---|
Case report: Mycobacterium monacense isolated from the blood culture of a patient with pulmonary infection.
Topics: Adult; Blood Culture; Cefoperazone; China; DNA, Ribosomal; Humans; Linezolid; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Pneumonia, Bacterial; Sulbactam; Voriconazole | 2020 |
Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Cefoperazone; Dexamethasone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Egg Yolk; Enzyme-Linked Immunosorbent Assay; Immunoglobulins; Injections, Intraperitoneal; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Sulbactam; Tumor Necrosis Factor-alpha | 2017 |
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins | 2014 |
[Treatment approaches for bronchopulmonary infection in myasthenia gravis patients].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchopneumonia; Cefoperazone; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myasthenia Gravis; Pneumonia, Bacterial; Sulbactam; Treatment Outcome | 2014 |
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
[Sulperazone in the treatment of severe infections in patients with cancer].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections | 2003 |
Cefoperazone induced gastrointestinal haemorrhage.
Topics: Aged; Cefoperazone; Cellulitis; Cephalosporins; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Male; Pneumonia, Bacterial | 1999 |